Many different monoclonal antibodies are already available to treat cancer. Some are licensed to treat particular types of cancer. Some newer types are still in clinical trials. Different monoclonal antibodies cause different side effects. It can take a long time to develop this type of treatment because making monoclonal antibodies can be very complicated. OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals. OMICS Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. It follows an Open Access publication model that enables the dissemination of research articles to the global community free of cost.
Research Article: Journal of Health & Medical Informatics
Research Article: Journal of Health & Medical Informatics
Research Article: Journal of Health & Medical Informatics
Research Article: Journal of Health & Medical Informatics
Short Communication: Journal of Health & Medical Informatics
Short Communication: Journal of Health & Medical Informatics
Case Report: Journal of Health & Medical Informatics
Case Report: Journal of Health & Medical Informatics
Research Article: Journal of Health & Medical Informatics
Research Article: Journal of Health & Medical Informatics
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Journal of Health & Medical Informatics received 2700 citations as per Google Scholar report